Comprehensive Molecular Characterization of Papillary Renal-Cell Carcinoma - Wikidata - awgldk - TriplyDB

Comprehensive Molecular Characterization of Papillary Renal-Cell Carcinoma

Comprehensive Molecular Characterization of Papillary Renal-Cell Carcinoma

http://www.wikidata.org/entity/Q36642291

about

Current Insights into Long Non-Coding RNAs in Renal Cell Carcinoma Oncometabolites: Unconventional triggers of oncogenic signalling cascades Choosing the right cell line for renal cell cancer research Renal cell carcinoma.Renal cell cancer: overview of the current therapeutic landscape.TCGA Expedition: A Data Acquisition and Management System for TCGA Data.TCGA Workflow: Analyze cancer genomics and epigenomics data using Bioconductor packages Knowledge about the presence or absence of miRNA isoforms (isomiRs) can successfully discriminate amongst 32 TCGA cancer types Whole-genome analysis of papillary kidney cancer finds significant noncoding alterations Identifying biomarkers of papillary renal cell carcinoma associated with pathological stage by weighted gene co-expression network analysis.MicroRNAs in biofluids are novel tools for bladder cancer screening.Genomic landscape and evolution of metastatic chromophobe renal cell carcinoma.Negative regulation of EGFR signalling by the human folliculin tumour suppressor protein Next-Generation Sequencing in Oncology: Genetic Diagnosis, Risk Prediction and Cancer Classification.An integrative study on the impact of highly differentially methylated genes on expression and cancer etiology Multilevel Genomics-Based Taxonomy of Renal Cell Carcinoma.Improving our understanding of papillary renal cell carcinoma with integrative genomic analysis.Comprehensive characterization of the perioperative morbidity of cytoreductive nephrectomy.Alternate Metabolic Programs Define Regional Variation of Relevant Biological Features in Renal Cell Carcinoma Progression.Insights into the Genetic Basis of the Renal Cell Carcinomas from The Cancer Genome Atlas.Unique Transcriptomic Profile of Collecting Duct Carcinomas Relative to Upper Tract Urothelial Carcinomas and other Kidney Carcinomas.Precision Oncology: Identifying Predictive Biomarkers for the Treatment of Metastatic Renal Cell Carcinoma The multi-omic landscape of transcription factor inactivation in cancer.Modelling TFE renal cell carcinoma in mice reveals a critical role of WNT signaling Molecular analysis of aggressive renal cell carcinoma with unclassified histology reveals distinct subsets.A comparative analysis and guidance for individualized chemotherapy of stage II and III colorectal cancer patients based on pathological markers Fumarate is an epigenetic modifier that elicits epithelial-to-mesenchymal transition DiseaseMeth version 2.0: a major expansion and update of the human disease methylation database.MET exon 14 juxtamembrane splicing mutations: clinical and therapeutical perspectives for cancer therapy.Cabozantinib: an Active Novel Multikinase Inhibitor in Renal Cell Carcinoma.Wide spetcrum mutational analysis of metastatic renal cell cancer: a retrospective next generation sequencing approach.Genomic differences between black and white patients implicate a distinct immune response to papillary renal cell carcinoma.Improving needle biopsy accuracy in small renal mass using tumor-specific DNA methylation markers Meta-analysis of gene expression and integrin-associated signaling pathways in papillary renal cell carcinoma subtypes.RBM10-TFE3 Renal Cell Carcinoma: A Potential Diagnostic Pitfall Due to Cryptic Intrachromosomal Xp11.2 Inversion Resulting in False-negative TFE3 FISH.Papillary renal cell carcinoma-derived chemerin, IL-8, and CXCL16 promote monocyte recruitment and differentiation into foam-cell macrophages.UALCAN: A Portal for Facilitating Tumor Subgroup Gene Expression and Survival Analyses.Renal cell tumors with clear cell histology and intact VHL and chromosome 3p: a histological review of tumors from the Cancer Genome Atlas database.Current Clinical Practice Guidelines for the Treatment of Renal Cell Carcinoma: A Systematic Review and Critical Evaluation.Sarcomatoid renal cell carcinoma has a distinct molecular pathogenesis, driver mutation profile and transcriptional landscape.

P2860

Q26752381-4255F509-DECF-4DCF-BFAC-C7E860C55E03 Q28069594-1C5941EE-95F3-4A32-90EE-69659DCDAD14 Q28073283-8B719CFC-4255-4435-A8CD-D9586EDD81D9 Q30235364-F7076F59-6678-4D35-A164-572A24518CE4 Q30248354-174564BB-2A9C-4CCB-B38B-D942A7FAE712 Q31139437-AB283027-0AEB-4BFF-A9BC-D110356279C3 Q31165459-6DC463AA-2539-4076-A3CB-4ADAF18118EA Q33557718-32689C2F-6457-4C3A-BFBD-DE26CBBB4AC8 Q33563168-DA4B5E6E-7E38-4AEA-8432-E486A594DB2D Q33709494-38C44DF5-208D-446A-BDC4-46545A5E3D53 Q33762123-D8CA9A8B-99A0-4DC4-BF0E-DD6F642680A0 Q33798092-61599117-C1D4-4A72-84FA-5583A477E0D5 Q33861388-5AAE122A-E106-4FA0-A4C0-E43A7B587E1A Q34550417-603F37C5-E90A-42BD-9477-CA312ED2F1EC Q36274178-7018BC87-BEB0-4AC1-B4F0-67F1E29E5304 Q36693159-B1D766EA-E10B-4CFB-AC5F-38FA408DB13C Q36829230-4960156F-DD4B-42A6-BF7A-D1B2FBE3D4B8 Q36969971-AB6D0671-273D-4EC8-B6F8-EE17AC681A21 Q37014111-FE76B40C-2E97-4D0B-9219-5C7261CFC203 Q37114357-8948E81D-5AEB-45F0-9DD1-7D487AB58E81 Q37148031-0B521DC7-8079-41A9-95F6-5D42E31C259F Q37179808-CBCC2062-8689-4F5B-94E3-F6AFFC165C4B Q37203595-B2567BFC-F0C7-48C7-9220-98D206806953 Q37284328-B7EEC180-BC15-4BA9-8EF2-FDCDC41A7A14 Q37330688-23FBA644-CA94-4043-AA7B-ECCD3A3A9CA7 Q37413869-67A367DB-57FF-431C-9E81-634E89392C26 Q37470652-C00D20CD-38D3-4C29-AF78-6B9A46078C26 Q37556882-0B736865-8DB3-4B2E-9724-804651D66020 Q37597858-15923D3C-EC95-4366-A49B-F60FD36C2277 Q37672483-D70B75A7-ADE2-4B0C-936C-A1F6E9D76E49 Q37702516-80C23377-E949-474E-97C6-EF2405AB4BE1 Q37706326-71B8A24F-CFA3-4FF9-B677-C9F3AE9957FB Q37706374-4340A217-A3C3-48D5-815E-7025A2A166A4 Q37708931-40D1FA3B-D3EF-41E6-B83B-00B7578FFAB0 Q38375566-B11035ED-9426-4DDA-962A-FEC6F961752E Q38651976-89EBEDFE-D318-4DC2-B333-290F34056F19 Q38667837-E6F58570-CF56-497B-88A3-8A57C145186B Q38668393-37A72957-1AD5-4D90-8597-479B52D6F6E5 Q38673512-55D475A0-1478-47A2-B5B6-340E309B62C8 Q38678106-D974C9C7-5D6C-4D93-9DC3-47F56A6A9F59

P2860

Comprehensive Molecular Characterization of Papillary Renal-Cell Carcinoma

http://www.wikidata.org/entity/Q36642291

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Comprehensive Molecular Characterization of Papillary Renal-Cell Carcinoma

@ast

Comprehensive Molecular Characterization of Papillary Renal-Cell Carcinoma

@en

type

label

Comprehensive Molecular Characterization of Papillary Renal-Cell Carcinoma

@ast

Comprehensive Molecular Characterization of Papillary Renal-Cell Carcinoma

@en

prefLabel

Comprehensive Molecular Characterization of Papillary Renal-Cell Carcinoma

@ast

Comprehensive Molecular Characterization of Papillary Renal-Cell Carcinoma

@en

P1433

Q36642291-CD6D2E6E-F89C-454C-ABFE-08C1679BA6D8

P1476

Q36642291-BD82272B-DA3A-4969-965A-02FB294BB368

P2093

Q36642291-039CC26B-4FCE-41D8-B13C-0DEBF8616971

Q36642291-060A13F3-A5A1-4DBF-B75C-9FBD69FB0232

Q36642291-07836B7B-E6EB-4DB9-8B6E-39AE86F5F9F0

Q36642291-0835826B-1DEC-48AD-B640-8C46A61FE691

Q36642291-0883F081-F641-4BA0-9E92-1EDBFA7DF88F

Q36642291-0E54A20A-CE12-43A3-9D86-E74EB7A52CD5

Q36642291-0F2F3730-DBBC-469C-9B14-FFA7C16F2C64

Q36642291-103CCCB3-3875-462D-84C2-424A5821BF05

Q36642291-11BCF0BB-AC6A-4F1E-8AA2-2B8EA6D9F94D

Q36642291-146316B1-F482-4638-8550-F95241515979

P2860

Q36642291-06A3D016-94EF-427A-B875-A76104DF545B

Q36642291-11D52A93-CD7D-461C-A135-8041D489CB97

Q36642291-142AA698-0081-431F-A445-93FEE1FF06B3

Q36642291-2361F075-061A-442E-9B4A-336D385991AC

Q36642291-23CE231C-F446-4567-8D7C-4ACAD04D8EE8

Q36642291-27F90C16-0668-477B-AEDA-0C18815E1A1C

Q36642291-2EC1FEEF-F9B2-4D57-8E59-A160F221B901

Q36642291-3104FD70-CFB7-4C34-8F2E-1B7E348FECBA

Q36642291-3ACDEB42-26AD-4D28-966A-F32E25482F7A

Q36642291-3F9273F8-B3A6-4EFC-9D17-38D6F870B2F3

P304

Q36642291-BDA6434C-221B-4A7B-8480-689D7305FE54

P31

Q36642291-8063E0BB-84A8-4E9B-B240-C366E30AF97F

P356

Q36642291-54F9E7F6-76BC-4384-8152-63595C73F545

P407

Q36642291-054CCAA7-4845-43FC-9736-FCE84D9B6058

P433

Q36642291-9F1B5B0B-8C71-44C0-8723-5CBF63A5DBCF

P478

Q36642291-F993DCEE-E50E-41BC-A4C9-5E0E6435C2FC

P50

Q36642291-18119E78-4E2E-48FF-B4A1-270177551FD9

Q36642291-1C4B3D75-3611-467D-A8EB-653D6A89448F

Q36642291-587C3600-438D-4809-A2AE-951D666C9D2C

Q36642291-6582E5E8-04E9-4043-A39B-0BFCC0F2467D

Q36642291-75C1E27E-7727-4E09-8E5A-473001236843

Q36642291-7685314D-558F-4FE4-9ACC-53D196465FD5

Q36642291-78F0CBF5-3A18-45E8-B14B-7553356D5C90

Q36642291-7CCE0BC6-9FBD-49A3-86FD-DBC30186A1A9

Q36642291-8B9B450E-6E1B-41B0-A338-8A826A35E747

Q36642291-A20F92FE-9503-4586-8A24-6443B2011487

P577

Q36642291-9223A4A5-7C1B-43F5-A502-6759B954F17D

P698

Q36642291-200F9318-BB3C-46A5-B731-6FF3708D18FB

P932

Q36642291-8A29DB98-2244-43E1-BEC7-35F4124BE482

P356

P1433

The New England Journal of Medicine

P1476

Comprehensive Molecular Characterization of Papillary Renal-Cell Carcinoma

@en

P2093

A Ari Hakimi

http://www.w3.org/2001/XMLSchema#string

A Gordon Robertson

http://www.w3.org/2001/XMLSchema#string

Abu Amar M Al Mamun

http://www.w3.org/2001/XMLSchema#string

Adrian Ally

http://www.w3.org/2001/XMLSchema#string

Alan P Hoyle

http://www.w3.org/2001/XMLSchema#string

Alicia Hawes

http://www.w3.org/2001/XMLSchema#string

Amanda Clarke

http://www.w3.org/2001/XMLSchema#string

Amie Radenbaugh

http://www.w3.org/2001/XMLSchema#string

Andrew D Cherniack

http://www.w3.org/2001/XMLSchema#string

Andrew K Godwin

http://www.w3.org/2001/XMLSchema#string

P2860

Identification of a CpG island methylator phenotype that defines a distinct subgroup of glioma

Comprehensive molecular portraits of human breast tumours

Nrf1 and Nrf2 positively and c-Fos and Fra1 negatively regulate the human antioxidant response element-mediated expression of NAD(P)H:quinone oxidoreductase1 gene

The epidermal growth factor receptor variant III (EGFRvIII): where wild things are altered

The two faces of Hippo: targeting the Hippo pathway for regenerative medicine and cancer treatment

Discovery and optimization of potent and selective triazolopyridazine series of c-Met inhibitors

Phase II and biomarker study of the dual MET/VEGFR2 inhibitor foretinib in patients with papillary renal cell carcinoma

Comprehensive molecular characterization of clear cell renal cell carcinoma.

Comprehensive molecular characterization of gastric adenocarcinoma

Comprehensive molecular profiling of lung adenocarcinoma.

P304

135-145

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1056/NEJMOA1505917

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

374

http://www.w3.org/2001/XMLSchema#string

P50

Charles M. Perou

Donald P. Bottaro

Jodi K. Maranchie

Matthew Meyerson

P577

2015-11-04T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26536169

http://www.w3.org/2001/XMLSchema#string

P932

4775252

http://www.w3.org/2001/XMLSchema#string